Faeth Therapeutics, Inc.
FTH
$32.34
$3.7913.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -195.53M | -184.46M | -21.09M | -24.14M | -26.82M |
| Total Depreciation and Amortization | 123.00K | 135.00K | 139.00K | 436.00K | 734.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.99M | 147.64M | 2.09M | 2.95M | 3.32M |
| Change in Net Operating Assets | 10.56M | 12.59M | -1.59M | -1.63M | -1.49M |
| Cash from Operations | -33.86M | -24.09M | -20.45M | -22.38M | -24.27M |
| Capital Expenditure | -6.00K | -22.00K | -16.00K | -16.00K | -16.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 210.00K | 250.00K | 250.00K | 250.00K |
| Cash Acquisitions | 6.46M | 6.46M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -142.14M | -25.51M | 19.54M | 14.31M | 25.48M |
| Cash from Investing | -135.68M | -18.86M | 19.77M | 14.54M | 25.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -345.00K | -641.00K | -790.00K | -884.00K | -936.00K |
| Issuance of Common Stock | 1.13M | 1.04M | 7.00K | 18.00K | 18.00K |
| Repurchase of Common Stock | -1.00K | -1.00K | -4.00K | -4.00K | -3.00K |
| Issuance of Preferred Stock | 200.00M | 200.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.91M | -15.00M | 142.00K | 142.00K | 141.00K |
| Cash from Financing | 183.88M | 185.40M | -645.00K | -728.00K | -780.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.35M | 142.45M | -1.33M | -8.57M | 666.00K |